Award
National Heart, Lung, and Blood Institute 5R01HL176882-02
Clinical Implementation of Blood Pressure Polygenic Risk Score: A Randomized Clinical Trial
Recipient
University of Alabama at Birmingham
Award Amount
$726,809.00
Ceiling
$726,809.00
Awarded
June 03, 2026
Identifier
5R01HL176882-02
A randomized clinical trial funded by the National Heart Lung and Blood Institute to evaluate the impact of blood pressure polygenic risk score dissemination on blood pressure control and related health outcomes in hypertensive adults.
Description
This project involves a randomized controlled clinical trial to assess the efficacy of SBP PRS dissemination on SBP control, adherence to a healthy lifestyle, and cardiometabolic profile in hypertensive young and middle-aged adults in the United States. The study is funded by the NHLBI and conducted by the University of Alabama at Birmingham.